Markus Obermueller

Statistics

Publications

Citations

124

H-Index

Active since

2018

Affiliations

Medical University of Vienna(Current)

Markus Obermueller is an author at Medical University of Vienna specializing in antibiotic resistance, infectious diseases, and antimicrobial pharmacotherapy.

Publications per year

2018–2021

Publications

Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible <i>Staphylococcus aureus</i> during treatment of a cardiac device-related endocarditis

Manuel Kussmann, Matthias Karer, Markus Obermueller et al. · Emerging Microbes & Infections · 2018 · 71 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Treatment of mucosa associated lymphoid tissue lymphoma with a long‐term once‐weekly regimen of oral azithromycin: Results from the phase II MALT—A trial

Heimo Lagler, Barbara Kiesewetter, Werner Dolak et al. · Hematological Oncology · 2018 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model

Manuel Kussmann, Markus Obermueller, Florian Berndl et al. · Scientific Reports · 2018 · 18 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Synergistic Effect of Cefazolin Plus Fosfomycin Against Staphylococcus aureus in vitro and in vivo in an Experimental Galleria mellonella Model

Manuel Kussmann, Markus Obermueller, Matthias Karer et al. · Frontiers in Pharmacology · 2021 · 10 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +15

1–4 of 4